EDIT catalyst calendar

Editas Medicine, Inc.

Upcoming catalysts
1
Cash runway
27.5 months
Cash & investments
$212M

Editas Medicine, Inc. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Biological Products, (No Diagnostic Substances).

The next scheduled catalyst is Next quarterly earnings (projected) on November 5, 2026, a projected date rather than a confirmed one. There is 1 upcoming event on record.

Cash runway is approximately 27.5 months based on the most recent reported cash position and quarterly operating burn as of 2026-06-30.

Upcoming catalysts

DateEventTypePhase
November 5, 2026 est. Next quarterly earnings (projected) Earnings —

Track EDIT alongside other companies. Add it to a watchlist and see every catalyst on one calendar.

Open EDIT in the tracker

Recent history

DateEventTypePhase
October 8, 2026 8-K filed: Reg FD disclosure, Other event Filing —
August 5, 2026 Quarterly results filed (8-K) Earnings —
May 26, 2026 8-K filed: Reg FD disclosure, Other event Filing —
May 26, 2026 8-K filed: Other event Filing —
May 26, 2026 8-K filed: Material agreement, Other event Corporate —
May 14, 2026 8-K filed: Reg FD disclosure, Other event Filing —
May 5, 2026 Quarterly results filed (8-K) Earnings —
March 27, 2026 8-K filed: Reg FD disclosure, Other event Filing —
March 9, 2026 Quarterly results filed (8-K) Earnings —
November 10, 2025 Quarterly results filed (8-K) Earnings —
October 9, 2025 8-K filed: Reg FD disclosure, Other event Filing —
September 15, 2025 EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) Trial Milestone Phase 1/Phase 2
September 2, 2025 8-K filed: Reg FD disclosure, Other event Filing —
August 15, 2025 A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY) Trial Milestone Phase 1/Phase 2
August 12, 2025 Quarterly results filed (8-K) Earnings —
June 12, 2025 8-K filed: Reg FD disclosure, Other event Filing —
June 2, 2025 8-K filed: Leadership change Corporate —
May 14, 2025 8-K filed: Reg FD disclosure, Other event Filing —
May 13, 2025 8-K filed: Reg FD disclosure, Other event Filing —
May 12, 2025 Quarterly results filed (8-K) Earnings —

About this data

Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.

Last updated 2026-10-14.